12:00 AM
Dec 23, 2013
 |  BC Week In Review  |  Company News  |  Deals

Advaxis, Taiwan Biotech deal

Taiwan Biotech formed Global BioPharma Inc. to develop and commercialize ADXS-HPV. Advaxis granted Global BioPharma exclusive rights to develop and commercialize ADXS-HPV in Asia, Africa and former USSR territory, excluding India and certain other countries, for all HPV-associated indications. Global BioPharma will make an undisclosed upfront equity investment in Advaxis. Global BioPharma will also have the option...

Read the full 275 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >